IMPROVING LIVES AROUND THE WORLD BY ACCELERATED IVD DEVELOPMENT
The Medtechtomarket team has worked together directly for over 25 years developing, producing and launching products in over 50 countries worldwide.
Medtechtomarket is a bespoke contract development and manufacturing organisation providing a full life-cycle service to develop your medical diagnostics from concept through to commercial launch.
Turning your technology ideas into commercial reality.
Our facilities are accredited to EN ISO13485:2016
Our expert team is composed of a wide range of skills.
Developing, producing and launching products worldwide.
The Medtechtomarket team has worked together directly for over 25 years developing, producing and launching products in over 50 countries worldwide.
We take your idea from concept through to commercialisation; from design to development, regulatory and clinical trials through to validation and product manufacturing.
Working in close partnership with our clients, we become an extension of your team to develop a robust, compliant and commercially viable products ready for launch.
Developing a range technologies with a direct measurement of biomarkers, tissue sample or directly to the patient.
We provide the entire lifecycle, from concept to commercial launch in <4 years for fully CE / FDA compliant and accredited products.
We have found Medtechtomarket to be a productive and professional development partner for a number of projects with the University of Liverpool. These include grant-funded projects in early technology applications and proof of concept, medical device development and prototyping and full in vitro diagnostic development. Throughout our time working with Medtechtomarket, their clear focus on clinical needs and ensuring technologies and products are industry-ready, has progressed each project successfully in a surprisingly short time frame.
”Medtechtomarket has been our development and manufacturing partner in the development of our diagnostic test for prostate cancer. During that time, they have demonstrated their expertise and knowledge of IVD product design, development and manufacture and supported our business more widely. Acting as an extension of our R&D team, their flexible, methodical and milestone-centred approach has been transparent, productive, and seamless.
”Our company has worked closely with Medtechtomarket for more than three years in the development of an in vitro diagnostic instrument to assess the functioning of a patient’s hemostatic system. From the beginning of the engagement, we were impressed with Dr. Pearce and his team’s knowledge and experience involving diagnostic instrument design, development, and manufacturing.
”Working in close partnership with our clients, we develop robust, compliant and commercially viable products ready for launch in the chosen market.
Working with a client based in the USA, we developed, manufactured and launched the world’s first…
Medtechtomarket developed a urine collection and monitoring system for adults using indwelling catheters. Our system offered…
Medtechtomarket developed a wireless ECG device for use by professionals in primary, acute and hyper-acute care…
There are approximately 123,000 cases and around 46,000 associated deaths from sepsis reported in England each…
Our highly qualified team combine their expertise across a range of technologies and disciplines along with their seamlessly integrated approach to develop medical diagnostics products at our accredited facilities.
From ECG technologies, viscosity measurements, microscopic vision systems and mechanical techniques, Medtechtomarket has developed a number of products that deliver diagnosis with a direct measurement of the patient or on the sample itself.
At Medtechtomarket, we have wide-ranging experience in developing technical optical test cartridge formats and instrumentation to deliver highly sensitive colormetric, turbidity or fluorescence assay detection systems for measuring single biomarkers, enzyme assays and panels.
From state-of-the-art microfluidic immunofluorescence to traditional lateral flow technologies, we employ a range of immunological techniques to determine markers for clinical chemistry and haematology point of care diagnostic applications.
Utilising passive and active continuous-flow microfluidic approaches to channel blood and reagent samples into micro-cuvettes, flow channels, reaction chambers, electrochemistry and MEMS sensors we are able to measure a wide range of biochemical markers in a number of clinical applications.
The MedtechtoMarket team has worked together directly for over 25 years developing, producing and launching products in over 50 countries worldwide.